Cost analysis of hemophilia treatment in a Brazilian public blood center

• Κύριοι συγγραφείς: Adriana Aparecida Ferreira (Συγγραφέας), Igor Vilela Brum (Συγγραφέας), João Vítor de Lanna Souza (Συγγραφέας), Isabel Cristina Gonçalves Leite (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Instituto de Estudos em Saúde Coletiva da Universidade Federal do Rio de Janeiro, 2020-12-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Background hemophilia is a rare coagulopathy, treated by replacing the missing blood clotting factor. Objective to assess the direct costs of hemophilia treatment from the perspective of the Unified Health System, highlighting the impact costs of new therapeutic modalities. Method partial e...